DiscGenics
PrivateLast Round
Series C
Aug 25, 2020
Total Funding Raised
$79.76M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DiscGenics is a biopharmaceutical company that develops regenerative cell-based therapies to alleviate pain and restore function in patients with degenerative spinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DiscGenics Comparables
Compare DiscGenics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mesoblast Limited | 83% | |
| BioRestorative Therapies, Inc. | 82% | |
| VIVEX Biologics | 81% |
DiscGenics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 25, 2020 | ||||
| Debt | Apr 14, 2020 | ||||
| Series B | Sep 26, 2017 | ||||
| Series A | Nov 30, 2013 | ||||
| Series A | Oct 5, 2011 |
Key People
Founding team and executive leadership
DiscGenics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NT Investments | Series C, Series B |
| Medical Incubator Japan | Series C |
| Mitsubishi UFJ Capital | Series C, Series B |
| Ci:z Investment LLP | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 144% MoM, reaching 3.8K.
- Apr 9, 2025
Opened a cGMP facility for scalable cell manufacturing in Salt Lake City.
DiscGenics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DiscGenics's valuation, stock price, and market status.
Is DiscGenics a public or private company?
DiscGenics is a private company.
What is the current stock price of DiscGenics?
DiscGenics is a private company with no public stock price. No recent secondary market data is available.
How much is DiscGenics worth (valuation)?
Valuation information for DiscGenics is not publicly available.
Can I buy DiscGenics stock?
DiscGenics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DiscGenics's last funding round?
DiscGenics's most recent funding round was Series C on August 25, 2020.
Who are the main investors in DiscGenics?
Key investors in DiscGenics include Ci:z Investment LLP.
Will DiscGenics IPO soon?
No public IPO plans have been announced for DiscGenics.
How can I track DiscGenics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DiscGenics's secondary market activity and sign up for updates.